Kenvue Inc. Logo

Kenvue Inc.

KVUE

(1.0)
Stock Price

23,19 USD

17.85% ROA

11.42% ROE

26.8x PER

Market Cap.

41.995.951.404,00 USD

77.93% DER

1.82% Yield

9.87% NPM

Kenvue Inc. Stock Analysis

Kenvue Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Kenvue Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

2 ROE

The stock's ROE falls within an average range (9.76%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 DER

The stock has a reasonable amount of debt compared to its ownership (78%), suggesting a balanced financial position and a moderate level of risk.

4 PBV

The stock's elevated P/BV ratio (3.28x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-45), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Kenvue Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Kenvue Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Kenvue Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Kenvue Inc. Revenue
Year Revenue Growth
2019 14.324.000.000
2020 14.467.000.000 0.99%
2021 15.054.000.000 3.9%
2022 14.950.000.000 -0.7%
2023 15.660.000.000 4.53%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Kenvue Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2019 0
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Kenvue Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 0
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Kenvue Inc. EBITDA
Year EBITDA Growth
2019 3.721.000.000
2020 7.741.000.000 51.93%
2021 3.855.000.000 -100.8%
2022 3.347.000.000 -15.18%
2023 2.740.000.000 -22.15%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Kenvue Inc. Gross Profit
Year Gross Profit Growth
2019 7.662.000.000
2020 7.848.000.000 2.37%
2021 8.419.000.000 6.78%
2022 8.285.000.000 -1.62%
2023 9.000.000.000 7.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Kenvue Inc. Net Profit
Year Net Profit Growth
2019 1.435.000.000
2020 -879.000.000 263.25%
2021 2.031.000.000 143.28%
2022 2.087.000.000 2.68%
2023 1.752.000.000 -19.12%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Kenvue Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 1
2020 0 0%
2021 1 100%
2022 1 0%
2023 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Kenvue Inc. Free Cashflow
Year Free Cashflow Growth
2019 2.709.000.000
2020 3.168.000.000 14.49%
2021 39.000.000 -8023.08%
2022 2.150.000.000 98.19%
2023 665.000.000 -223.31%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Kenvue Inc. Operating Cashflow
Year Operating Cashflow Growth
2019 2.998.000.000
2020 3.397.000.000 11.75%
2021 334.000.000 -917.07%
2022 2.525.000.000 86.77%
2023 742.000.000 -240.3%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Kenvue Inc. Capital Expenditure
Year Capital Expenditure Growth
2019 289.000.000
2020 229.000.000 -26.2%
2021 295.000.000 22.37%
2022 375.000.000 21.33%
2023 77.000.000 -387.01%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Kenvue Inc. Equity
Year Equity Growth
2020 18.356.000.000
2021 20.399.000.000 10.02%
2022 20.021.000.000 -1.89%
2023 11.040.000.000 -81.35%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Kenvue Inc. Assets
Year Assets Growth
2020 29.177.000.000
2021 27.929.000.000 -4.47%
2022 27.316.000.000 -2.24%
2023 27.542.000.000 0.82%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Kenvue Inc. Liabilities
Year Liabilities Growth
2020 10.821.000.000
2021 7.530.000.000 -43.71%
2022 7.295.000.000 -3.22%
2023 16.502.000.000 55.79%

Kenvue Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8.11
Net Income per Share
0.82
Price to Earning Ratio
26.8x
Price To Sales Ratio
2.7x
POCF Ratio
14.37
PFCF Ratio
16.6
Price to Book Ratio
3.81
EV to Sales
3.18
EV Over EBITDA
17.22
EV to Operating CashFlow
16.88
EV to FreeCashFlow
19.51
Earnings Yield
0.04
FreeCashFlow Yield
0.06
Market Cap
42,00 Bil.
Enterprise Value
49,37 Bil.
Graham Number
10.3
Graham NetNet
-6.37

Income Statement Metrics

Net Income per Share
0.82
Income Quality
1.7
ROE
0.09
Return On Assets
0.05
Return On Capital Employed
0.11
Net Income per EBT
0.7
EBT Per Ebit
0.87
Ebit per Revenue
0.16
Effective Tax Rate
0.3

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.56
Operating Profit Margin
0.16
Pretax Profit Margin
0.14
Net Profit Margin
0.1

Dividends

Dividend Yield
0.02
Dividend Yield %
1.82
Payout Ratio
0
Dividend Per Share
0.4

Operating Metrics

Operating Cashflow per Share
1.53
Free CashFlow per Share
1.32
Capex to Operating CashFlow
-0.13
Capex to Revenue
-0.03
Capex to Depreciation
-0.64
Return on Invested Capital
0.09
Return on Tangible Assets
0.18
Days Sales Outstanding
64.31
Days Payables Outstanding
124.54
Days of Inventory on Hand
107.19
Receivables Turnover
5.68
Payables Turnover
2.93
Inventory Turnover
3.41
Capex per Share
-0.21

Balance Sheet

Cash per Share
0,64
Book Value per Share
5,76
Tangible Book Value per Share
-4.03
Shareholders Equity per Share
5.76
Interest Debt per Share
4.57
Debt to Equity
0.78
Debt to Assets
0.31
Net Debt to EBITDA
2.57
Current Ratio
1.17
Tangible Asset Value
-7,72 Bil.
Net Current Asset Value
-10,28 Bil.
Invested Capital
0.78
Working Capital
0,92 Bil.
Intangibles to Total Assets
0.68
Average Receivables
2,55 Bil.
Average Payables
2,07 Bil.
Average Inventory
2124000000
Debt to Market Cap
0.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Kenvue Inc. Dividends
Year Dividends Growth
2023 0

Kenvue Inc. Profile

About Kenvue Inc.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

CEO
Mr. Thibaut Mongon
Employee
22.000
Address
199 Grandview Road
Skillman, 08558

Kenvue Inc. Executives & BODs

Kenvue Inc. Executives & BODs
# Name Age
1 Mr. Matthew Orlando
General Counsel
70
2 Mr. Carlton Lawson
Group President of Europe, Middle East & Africa
70
3 Mr. Paul Ruh
Chief Financial Officer
70
4 Ms. Heather R. Howlett
Chief Accounting Officer
70
5 Mr. Bernardo Tavares
Chief Data & Technology Officer
70
6 Dr. Caroline Tillett
Chief Scientific Officer
70
7 Ms. Tina Romani
Head of Investor Relations
70
8 Mr. Thibaut Mongon
Chief Executive Officer & Director
70
9 Ms. Ellie Bing Xie
Group President of Asia Pacific
70
10 Ms. Meredith Stevens
Chief Operations Officer
70

Kenvue Inc. Competitors